Ad Header



The Pulse of the Pharmaceutical Industry

GSK offers concessions to address EU concerns over Pfizer deal

Written by: | | Dated: Thursday, June 20th, 2019


BRUSSELS (Reuters) – GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer’s consumer health business, the European Commission said on Thursday.

The EU competition enforcer will decide by July 10 whether to accept the proposal, demand more or open a full-scale investigation, according to a filing on its site.

GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.


Reporting by Foo Yun Chee; Editing by Alissa de Carbonnel


Reuters source:

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom